Geron CORP
Doing business as C. T. CORPORATION SYSTEM (Previous Legal)
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersFoster City, CA
US patents205
SAM.gov UEIXEC8NJK1LPS3
CAGE code9NTB6
Incorporated inDE
LEI549300T282D7Z2YESL90
- medicines
- blood cancers
- myeloid hematologic malignancies
- development
- clinical trials
- lives
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
205 US patents granted 1996–2025, 14 of them in the five years to SEP 2025.
Pharmaceuticals 117Biotechnology 59Organic fine chemistry 24Measurement 4Chemical engineering 1
- Guanine analogs as telomerase substrates and telomere length affectorsUS 12,398,162 · granted AUG 26, 2025
- Use of a Janus kinase inhibitor and a telomerase inhibitor for the treatment of myeloproliferative neoplasmsUS 12,391,946 · granted AUG 19, 2025
- Process for preparing imetelstatUS 12,264,174 · granted APR 1, 2025
- Methods of treating myelodysplastic syndromeUS 12,201,645 · granted JAN 21, 2025
- Methods of treating myelodysplastic syndromeUS 12,171,778 · granted DEC 24, 2024
Newest 5 shown · Granted to Geron Corporation · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Geron CORP | Foster City | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.